Live from the NIH registry
Studies recruiting near Jackson right now
Top 25 of 227 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Incremental Hemodialysis: The TwoPlus Trial
End-Stage Kidney Disease
N/A
Interventional 350 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Wake Forest University Health Sciences
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
University of Mississippi Medical Center ( Site 0043) — Jackson, Mississippi (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Proven Endpoints LLC /ID# 270269 — Ridgeland, Mississippi (9.1 mi)
· Sponsor: AbbVie
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Jackson, Mississippi (2.0 mi)
· Sponsor: AstraZeneca
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt
Right-To-Left Shunt
Phase 3
Interventional 300 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: Agitated Solutions, Inc.
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Duke University
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 714 participants sought
Jackson Oncology Associates, PLLC — Jackson, Mississippi (2.0 mi)
· Sponsor: Pfizer
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Precise Research Centers — Flowood, Mississippi (4.3 mi)
· Sponsor: Bristol-Myers Squibb
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
Solid Tumor
Phase 1
Interventional 200 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Oxford BioTherapeutics Ltd
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: Novo Nordisk A/S
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Teen Mom Study Feasibility Trial
Physical Activity, Sedentary Behavior
N/A
Interventional 20 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: University of Mississippi Medical Center
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Proven Endpoints — Ridgeland, Mississippi (9.1 mi)
· Sponsor: Kallyope Inc.
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
Phase 3
Interventional 130 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: PedAL BCU, LLC
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Hypertension
N/A
Interventional 261 participants sought
Jackson Heart — Jackson, Mississippi (2.0 mi)
· Sponsor: SoniVie Inc.
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mississippi Retina Associates (Site 084) — Madison, Mississippi (11.6 mi)
· Sponsor: EyeBiotech Ltd.
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Basal Ganglia Germinoma, Diabetes Insipidus
Phase 2
Interventional 240 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Children's Oncology Group
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Type 2 Diabetes
Phase 3
Interventional 55 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Eli Lilly and Company
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: Amgen